PFM Health Sciences’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-384,995
| Closed | -$5.43M | – | 81 |
|
|
2022
Q2 | $5.43M | Buy |
+384,995
| New | +$5.43M | 0.21% | 69 |
|
|
2021
Q3 | – | Sell |
-2,807,310
| Closed | -$68.5M | – | 76 |
|
|
2021
Q2 | $68.5M | Buy |
2,807,310
+1,505,181
| +116% | +$36.7M | 2.15% | 16 |
|
|
2021
Q1 | $33.6M | Buy |
1,302,129
+42,655
| +3% | +$1.1M | 1.03% | 33 |
|
|
2020
Q4 | $67.3M | Buy |
1,259,474
+838,387
| +199% | +$44.8M | 2.37% | 6 |
|
|
2020
Q3 | $17.4M | Buy |
+421,087
| New | +$17.4M | 0.8% | 40 |
|
|
2015
Q2 | – | Sell |
-249,855
| Closed | -$8.14M | – | 85 |
|
|
2015
Q1 | $8.14M | Sell |
249,855
-43,710
| -15% | -$1.42M | 0.22% | 74 |
|
|
2014
Q4 | $9.32M | Sell |
293,565
-267,221
| -48% | -$8.48M | 0.22% | 76 |
|
|
2014
Q3 | $13.9M | Sell |
560,786
-1,071,389
| -66% | -$26.5M | 0.32% | 47 |
|
|
2014
Q2 | $36.9M | Buy |
1,632,175
+68,740
| +4% | +$1.55M | 0.74% | 39 |
|
|
2014
Q1 | $38M | Buy |
+1,563,435
| New | +$38M | 0.69% | 41 |
|